Jay Skyler
Direttore/Membro del Consiglio presso APPLIED THERAPEUTICS, INC.
Patrimonio netto: 13 M $ in data 31/05/2024
Profilo
Dr. Jay S.
Skyler, MD, is an Independent Director at Applied Therapeutics, Inc., a Professor at University of Miami and a Deputy Director & Professor at Diabetes Research Institute.
He is on the Board of Directors at SAB Biotherapeutics, Inc., Applied Therapeutics, Inc., Intarcia Therapeutics, Inc. and Moerae Matrix, Inc. /Nj/.
Dr. Skyler was previously employed as an Independent Director by Aerami Therapeutics, Inc., an Independent Director by DexCom, Inc., an Independent Director by Amylin Pharmaceuticals, Inc., a Member-Examining Board by American Board of Internal Medicine, a Member-Regents Board by American College of Physicians, a President by American Diabetes Association, a Vice President by International Diabetes Federation, a Chairman-Study by National Institute of Diabetes & Digestive & Kidney Diseases, and a President by Southern Society for Clinical Investigation.
He also served on the board at MiniMed, Inc. He received his undergraduate degree from The Pennsylvania State University and a doctorate degree from Sidney Kimmel Medical College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
DEXCOM, INC.
0.03% | 18/05/2023 | 103 348 ( 0.03% ) | 12 M $ | 31/05/2024 |
| 06/06/2024 | 65 000 ( 0.06% ) | 278 200 $ | 31/05/2024 |
Posizioni attive di Jay Skyler
| Società | Posizione | Inizio |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/04/2019 |
| SAB BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 06/05/2024 |
Moerae Matrix, Inc. /Nj/
 Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Moerae Matrix, Inc. is a biotechnology company based in Morristown, NJ. Moerae Matrix, Inc. develops novel therapies as a biotechnology company. The company was founded by Cynthia Lander, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 19/09/2017 |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | Corporate Officer/Principal | 01/01/2004 |
| Diabetes Research Institute | Corporate Officer/Principal | 01/01/1976 |
Precedenti posizioni note di Jay Skyler
| Società | Posizione | Fine |
|---|---|---|
| DEXCOM, INC. | Direttore/Membro del Consiglio | 18/05/2023 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 08/08/2012 |
| MiniMed, Inc. | Direttore/Membro del Consiglio | 01/01/2001 |
| ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Jay Skyler
| The Pennsylvania State University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| DEXCOM, INC. | Health Technology |
| APPLIED THERAPEUTICS, INC. | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| MiniMed, Inc. | Health Technology |
International Diabetes Federation
 International Diabetes Federation Miscellaneous Commercial ServicesCommercial Services The International Diabetes Federation (IDF) is an umbrella organization of over 240 national diabetes associations in 160 countries and territories. The private company is based in Brussels, Belgium. The mission of IDF is to promote diabetes care, prevention, and a cure worldwide. IDF advocates for people with diabetes and works towards its mission by collaborating with national diabetes associations, healthcare professionals, and policymakers. Founded in 1950, IDF represents the interests of the growing number of people with diabetes and those at risk. | Commercial Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron. | Commercial Services |
| National Institute of Diabetes & Digestive & Kidney Diseases | Government |
| Southern Society for Clinical Investigation | |
| Diabetes Research Institute | |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
American College of Physicians
 American College of Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Physicians operates as a medical-specialty organization. The non-profit company is based in Philadelphia, PA. Darilyn V. Moyer has been the CEO of the company since 2016. | Commercial Services |
Moerae Matrix, Inc. /Nj/
Moerae Matrix, Inc. /Nj/ Miscellaneous Commercial ServicesCommercial Services Moerae Matrix, Inc. is a biotechnology company based in Morristown, NJ. Moerae Matrix, Inc. develops novel therapies as a biotechnology company. The company was founded by Cynthia Lander, who has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Jay Skyler
